SMI Extends Winning Streak to 11 Days on Iran Peace Hopes, May 27

The Swiss Market Index rose 0.43% to 13,583.56 points on May 27, extending its winning streak to 11 consecutive trading days. Optimism over US-Iran negotiations and strong AI-linked earnings from US tech stocks drove the gains. However, analysts warn that market momentum may be slowing as investors face fatigue after weeks of strong gains.

SMI Maintains Momentum Despite Geopolitical Uncertainty

The SMI rose 0.43% to 13,583.56 points on May 27, building on its 10-day winning streak. The mid-cap SMIM index gained 0.29% to 3,003.32 points, while the broader SPI climbed 0.42% to 19,176.25 points. Investors showed renewed confidence as peace negotiations between the US and Iran progressed, despite ongoing military tensions in the region.

UBS strategists noted that a sustainable peace deal would remove lingering anxiety and allow focus to shift to earnings fundamentals. However, government bond yields remained volatile after hitting multi-year highs last week, with the 30-year US Treasury yield reaching its highest level since 2007.

Tech Gains Lift Swiss Equities, But Fatigue Sets In

AI-linked earnings continued to drive global markets higher. NVIDIA’s strong results reinforced demand for AI infrastructure, supporting tech stocks worldwide and benefiting Swiss equities. However, analysts warned that market fatigue may be emerging after weeks of substantial gains. One trader commented that concentration risk in leading US tech stocks has increased, making a diversified approach across the AI value chain more attractive.

The summer slowdown looms, and some market participants questioned how much further the AI euphoria can carry valuations. A broader recovery across sectors would require resolution of the Iran conflict and reopening of the Strait of Hormuz.

Gainers and Losers Shape the Day

Richemont led the SMI with a 4.1% gain, while Amrize jumped 3.8% on recovery buying after recent losses. Sika and Givaudan also outperformed, rising 2.4% each. Nestlé contributed positively with a 0.8% gain. Roche, however, declined 1.1% without news, weighing on the index. Novartis edged up just 0.1%, while defensive stocks like Swisscom fell 0.5%.

UBS highlighted that bond market volatility persists as investors assess the inflation impact of higher energy prices. Federal Reserve rate hike odds rose to 82% by December, though UBS views a hike as unlikely in the near term.

What Comes Next for Swiss Markets

With the SMI at 13,583.56 points, the index faces a critical test of momentum. Analysts expect the next driver to be either a confirmed Iran peace deal or fresh earnings surprises. Bond yields remain a headwind, with equity market conditions showing signs of consolidation. The summer period typically brings lower trading volumes, which could limit further upside unless major geopolitical risks are resolved.

Final Thoughts

The SMI’s 11-day winning streak reflects investor optimism on Iran peace and AI earnings, but fatigue signals caution. With the index at 13,583.56 and bond yields elevated, further gains depend on geopolitical resolution and sustained earnings growth.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.